欧盟无条件批准诺和控股收购药品代工商康泰伦特

界面
07 Dec 2024

欧盟委员会12月6日宣布,无条件批准诺和诺德大股东诺和控股(Novo Holdings)收购生物制药合同制造商康泰伦特的交易,定该交易不会在欧洲经济区引发竞争问题。诺和控股今年2月宣布,将以全现金交易形式收购康泰伦特,加上债务的企业总价值达到165亿美元。作为交易的一部分,诺和诺德将以110亿美元的预付款从诺和控股手中收购康泰伦特位于意大利阿纳尼、比利时布鲁塞尔和美国印第安纳州布卢明顿的三座灌装...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10